1001467-29-3

Basic information

• Product Name: C₁₉H₂₅N₃O₄
• CAS NO: 1001467-29-3
• Molecular Weight: 359.425
• Mol File: 1001467-29-3.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: C₁₉H₂₅N₃O₄(CAS DataBase Reference)
• NIST Chemistry Reference: C₁₉H₂₅N₃O₄(1001467-29-3)
• EPA Substance Registry System: C₁₉H₂₅N₃O₄(1001467-29-3)

Safety Data

• Hazardous Substances Data: 1001467-29-3(Hazardous Substances Data)

Upstream product

• 771-28-8 N'-hydroxy-2-methoxybenzenecarboximidamide 
• 6609-56-9 2-methoxy-benzonitrile 

Relevant articles and documents

COMPOUNDS HAVING AN ETHR INHIBITING ACTIVITY - USE OF SAID COMPOUNDS AS DRUGS - PHARMACEUTICAL COMPOSITION AND PRODUCT CONTAINING SAID COMPOUNDS

The present invention relates to compounds of Formula (I), wherein R1 is chosen among the following radicals : (II); (III); (IV), (V), (VI) (VII) and n= 1 or 2 and m=1 or 2 with the proviso that m=2 when R1 is (VIII). The present invention also relates to the use thereof as drugs, more particularly in the treatment of mycobacterial infections and more particularly in the treatment of tuberculosis.

COMPOUNDS HAVING A POTENTIATING EFFECT ON THE ACTIVITY OF ETHIONAMIDE AND USES THEREOF

The present invention relates to the use of compounds with a potentiating effect on the activity of antibiotics that are activatable via the EthA enzymatic pathway, for the preparation of a medicament for preventing and/or treating mycobacterial infections such as tuberculosis and leprosy, to pharmaceutical compositions comprising them in combination with an antibiotic that is activatable via the EthA pathway, to compounds having a potentiating effect on the activity of antibiotics that are activatable via the EthA enzymatic pathway, to pharmaceutical compositions comprising them and to their use as medicaments, especially medicaments for preventing and/or treating mycobacterial infections such as tuberculosis and leprosy.